bioMérieux sa Acquires AviaraDx Inc. for $60,000,000

  • Feed Type
  • Date
    9/11/2008
  • Company Name
    AviaraDx Inc.
  • Mailing Address
    11025 Roselle Street San Diego, CA 92121
  • Company Description
    AviaraDx discovers, develops, and commercializes new molecular diagnostic tests in oncology, enabling physicians to personalize cancer treatment through better understanding of the molecular biology underlying a patient’s tumor. Our tests improve the classification of cancer, support physicians to provide their patients with a more specific prognosis or individual risk assessment, and will eventually provide information critical to predict treatment response to a given therapeutic regimen.
  • Website
    http://www.aviaradx.com
  • Transaction Type
    M&A
  • Transaction Amount
    $60,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    French in-vitro diagnostics firm bioMerieux (BIOX.PA:) said on Thursday it bought privately held AviaraDx, Inc., based in San Diego, California for $60 million.

By posting a comment, you agree to our terms and conditions.